Detalhe da pesquisa
1.
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma.
Liver Int
; 44(7): 1588-1599, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38426262
2.
Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma: A Real-life Multicentric Weighted Comparison.
Ann Surg
; 275(4): 743-752, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35081572
3.
Metabolic disorders across hepatocellular carcinoma in Italy.
Liver Int
; 38(11): 2028-2039, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29745475
4.
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma.
Liver Int
; 37(3): 423-433, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27566596
5.
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma.
PLoS Med
; 13(4): e1002006, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27116206
6.
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care.
Dig Liver Dis
; 2024 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38341377
7.
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs.
JHEP Rep
; 5(8): 100784, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37520672
8.
Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer.
Front Immunol
; 13: 875072, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35677052
9.
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma.
Dig Liver Dis
; 54(9): 1215-1221, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35354543
10.
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors.
Dig Liver Dis
; 54(11): 1563-1572, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35906166
11.
Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B.
Gastroenterology
; 138(2): 682-93, 693.e1-4, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19800335
12.
Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma.
Cells
; 10(3)2021 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33802077
13.
Integrated prognostication of intrahepatic cholangiocarcinoma by contrast-enhanced computed tomography: the adjunct yield of radiomics.
Abdom Radiol (NY)
; 46(10): 4689-4700, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34165602
14.
Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life Setting.
J Clin Med
; 10(15)2021 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34361985
15.
Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCs.
Cancers (Basel)
; 13(4)2021 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33546234
16.
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment.
Eur J Cancer
; 158: 133-143, 2021 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34666215
17.
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study.
Dig Liver Dis
; 53(8): 1011-1019, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33353858
18.
A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study.
Cancers (Basel)
; 13(11)2021 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34072309
19.
Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
Liver Cancer
; 10(2): 126-136, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33977089
20.
Natural killer cells phenotypic characterization as an outcome predictor of HCV-linked HCC after curative treatments.
Oncoimmunology
; 5(8): e1154249, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27622055